Outcomes in randomized controlled trials in psoriasis: What has changed over the last 20 years?

References

• Jobling R. G. Psoriasis – A preliminary questionnaire study of sufferers' subjective experience. Clin Exp Dermatol 1976; 1: 233–6
   PubMed Web of Science ®Google Scholar
• Jowett S., Ryan T. Skin disease and handicap: An analysis of the impact of skin conditions. Soc Sci Med 1985; 20: 425–9
   PubMed Web of Science ®Google Scholar
• Ashcroft D. M., Wan Po A. L., Williams H. C., Griffiths C. E. Clinical measures of disease severity and outcome in psoriasis: A critical appraisal of their quality. Br J Dermatol 1999; 141: 185–91
   PubMed Web of Science ®Google Scholar
• Marks R., Barton S. P., Shuttleworth D., Finlay A. Y. Assessment of disease progress in psoriasis. Arch Dermatol 1989; 125: 235–40
   PubMedGoogle Scholar
• Carroll C. L., Feldman S. R., Camacho F. T., Balkrishman R. Better medication adherence results in greater improvement in severity of psoriasis. Br J Dermatol 2004; 151: 895–7
   PubMed Web of Science ®Google Scholar
• Vahlquist A., Torma H., Carlsson B. Inefficacy of topical thyroid hormone analogue TriAc in plaque psoriasis: Results of a double‐blind placebo‐controlled trial. Br J Dermatol 2004; 151: 489–91
   Google Scholar
• Langley R. G., Ellis C. N. Evaluating psoriasis with Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician's Global Assessment. J Am Acad Dermatol 2004; 51: 563–9
   PubMed Web of Science ®Google Scholar
• Allan S. J., Kavanagh G. M., Herd R. M., Sarin J. A. The effect of inositol supplements on the psoriasis of patients taking lithium: A randomized, placebo‐controlled trial. Br J Dermatol 2004; 150: 966–9
   Google Scholar
• Kragballe K., Noerrelund K. L., Lui H., Ortonne J. P., Wozel J., Uurasmaa T., et al. Efficacy of once‐daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris. Br J Dermatol 2004; 150: 1167–73
   PubMed Web of Science ®Google Scholar
• Feldman S. R., Menter A., Koo J. Y. Improved health‐related quality of life following a randomized controlled trial of alefacept treatment in patients with chronic plaque psoriasis. Br J Dermatol 2004; 150: 317–26
   PubMed Web of Science ®Google Scholar
• Durakovic C., Ray S., Holick M. F. Topical paricalcitol (19‐nor‐1 alpha,25‐dihydroxyvitamin D2) is a novel, safe and effective treatment for plaque psoriasis: A pilot study. Br J Dermatol 2004; 151: 190–5
   PubMed Web of Science ®Google Scholar
• Grundmann‐Kollmann M., Ludwig R., Zollner T. M., Ochsendorf F., Thaci D., Boehncke W., et al. Narrowband UVB and cream psoralen‐UVA combination therapy for plaque‐type psoriasis. J Am Acad Dermatol 2004; 50: 734–9
   PubMed Web of Science ®Google Scholar
• Legat F. J., Hofer A., Quehenberger F., Kahofer P., Kerl H., Wolf P. Reduction of treatment frequency and UVA dose does not substantially compromise the antipsoriatic effect of oral psoralen‐UVA. J Am Acad Dermatol 2004; 51: 746–54
   Google Scholar
• Gribetz C., Ling M., Lebwohl M., Pariser D., Draelos Z., Gottlieb A. B., et al. Pimecrolimus cream 1% in the treatment of intertriginous psoriasis: A double‐blind, randomized study. J Am Acad Dermatol 2004; 51: 731–8
   PubMed Web of Science ®Google Scholar
• Lebwohl M., Freeman A. K., Chapman M. S., Feldman S. R., Hartle J. E., Henning A. Tacrolimus ointment is effective for facial and intertriginous psoriasis. J Am Acad Dermatol 2004; 51: 723–30
   PubMed Web of Science ®Google Scholar
• Opmeer B. C., Heydendael V. M., De Borgie C. A., Spuls P. I., Bossuyt P. M., Bos J. D., et al. Costs of treatment in patients with moderate to severe plaque psoriasis: economic analysis in a randomized controlled comparison of methotrexate and cyclosporine. Arch Dermatol 2004; 140: 685–90
   PubMed Web of Science ®Google Scholar
• Gottlieb A. B., Evans R., Li S., Dooley L. T., Guzzo C. A., Baker D., et al. Infliximab induction therapy for patients with severe plaque‐type psoriasis: A randomized, double‐blind, placebo‐controlled trial. J Am Acad Dermatol 2004; 51: 534–42
   PubMed Web of Science ®Google Scholar
• Van de Kerkhof P. C. The impact of a two‐compound product containing calcipotriol and betamethasone dipropionate (Daivobet/Dovobet) on the quality of life in patients with psoriasis vulgaris: A randomized controlled trial. Br J Dermatol 2004; 151: 663–8
   PubMed Web of Science ®Google Scholar
• Radakovic‐Fijan S., Blecha‐Thalhammer U., Schleyer V., Sziemies R. M., Zwingers T., Honigsmann H., et al. Topical aminolaevulinic acid‐based photodynamic therapy as a treatment option for psoriasis? Results of a randomized, observer‐blinded study. Br J Dermatol 2005; 152: 279–83
   PubMed Web of Science ®Google Scholar
• Asawanonda P., Chingchai A., Torranin P. Targeted UV‐B phototherapy for plaque‐type psoriasis. Arch Dermatol 2005; 141: 1542–6
   PubMedGoogle Scholar
• Carroll C. L., Clarke J., Camacho F., Balkrishman R., Feldman S. R. Topical tacrolimus ointment combined with 6% salicylic acid gel for plaque psoriasis treatment. Arch Dermatol 2005; 141: 43–6
   PubMed Web of Science ®Google Scholar
• Gottlieb A. B., Griffiths C. E., Ho V. C., Lahfa M., Mrowietz U., Murrell D. F., et al. Oral pimecrolimus in the treatment of moderate to severe chronic plaque‐type psoriasis: A double‐blind, multicentre, randomized, dose‐finding trial. Br J Dermatol 2005; 152: 1219–27
   PubMed Web of Science ®Google Scholar
• Ormerod A. D., Shah S. A., Copeland P., Omar G., Winfield A. Treatment of psoriasis with topical sirolimus: Preclinical development and a randomized, double‐blind trial. Br J Dermatol 2005; 152: 758–64
   PubMed Web of Science ®Google Scholar
• Leonardi C. L., Papp K. A., Gordon K. B., Menler A., Feldman S. R., Caro I., et al. Extended efalizumab therapy improves chronic plaque psoriasis: Results from a randomized phase III trial. J Am Acad Dermatol 2005; 52: 425–33
   PubMed Web of Science ®Google Scholar
• Dawe R. S., Yule S., Cameron H., Moseley H., Ibbotson S. H., Ferguson J. A randomized controlled comparison of the efficacy of Dead Sea salt balneophototherapy vs narrowband ultraviolet B monotherapy for chronic plaque psoriasis. Br J Dermatol 2005; 153: 613–19
   Google Scholar
• Krueger G. G., Langley R. G., Finlay A. Y., Griffiths C. E., Woolley J. M., Lalla D., et al. Patient‐reported outcomes of psoriasis improvement with etanercept therapy: Results of a randomized phase III trial. Br J Dermatol 2005; 153: 1192–9
   PubMed Web of Science ®Google Scholar
• Menter A., Gordon K., Carey W., Hamilton T., Glazer S., Caro I., et al. Efficacy and safety observed during 24 weeks of efalizumab therapy in patients with moderate to severe plaque psoriasis. Arch Dermatol 2005; 141: 31–8
   PubMed Web of Science ®Google Scholar
• Feldman S. R., Gordon K. B., Bala M., Evans R., Li S., Dooley L. T., et al. Infliximab treatment results in significant improvement in the quality of life of patients with severe psoriasis: A double‐blind placebo‐controlled trial. Br J Dermatol 2005; 152: 954–60
   PubMed Web of Science ®Google Scholar
• Papp K. A., Tyring S., Lahfa M., Prinz J., Griffiths C. E., Nakanishi A. M., et al. A global phase III randomized controlled trial of etanercept in psoriasis: Safety, efficacy, and effect of dose reduction. Br J Dermatol 2005; 152: 1304–12
   PubMed Web of Science ®Google Scholar
• Bissonnette R., Papp K., Poulin Y., Lauzon G., Aspeslets L., Huizinga R., et al. A randomized, multicenter, double‐blind, placebo‐controlled phase 2 trial of ISA247 in patients with chronic plaque psoriasis. J Am Acad Dermatol 2006; 54: 472–8
   PubMed Web of Science ®Google Scholar
• Naldi L., Svensson A., Diepgen T., Elsner P., Grob J., Goenraads P., et al. Randomized clinical trials for psoriasis 1977–2000: the EDEN survey. J Invest Dermatol 2003; 120: 738–41
   PubMed Web of Science ®Google Scholar
• Holm E. A., Jemec G. B. E. General Guidelines for Assessment of skin disease. Handbook of non‐invasive methods and the skin, J Serup, G. B. E Jemec, G Grove. CRC, Boca Ratron 2006; 931–42, 2nd ed
   Google Scholar
• Feldman S. R., Krueger G. G. Psoriasis assessment tools in clinical trials. Ann Rheum Dis 2005; 64(suppl 2)ii65–8
   PubMed Web of Science ®Google Scholar
• Feldman S. R. The design of clinical trials in psoriasis: Lessons for clinical practice. J Am Acad Dermatol 2003; 49: S62–5
   Web of Science ®Google Scholar
• Kirby B., Fortune D. G., Bhushan M., Chalmers R. J., Griffiths C. E. The Salford Psoriasis Index: An holistic measure of psoriasis severity. Br J Dermatol 2000; 142: 728–32
   PubMed Web of Science ®Google Scholar
• Jemec G. B., Wulf H. C. The applicability of clinical scoring systems: SCORAD and PASI in psoriasis and atopic dermatitis. Acta Derm Venereol 1997; 77: 392–3
   PubMed Web of Science ®Google Scholar
• Holm E. A., Wulf H. C., Stegmann H., Jemec G. B. Life quality assessment among patients with atopic eczema. Br J Dermatol 2006; 154: 719–25
   PubMed Web of Science ®Google Scholar